Mirae Asset Global Investments’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History
Bought
Maintained
Sold
Other funds holding LKFT
GS
AA
MAM
DO
QCM
EAM
CGH
CUAMC
Mirae Asset Global Investments's LKFT Position: Q2 2026 in Review
Mirae Asset Global Investments opened a new position in Lakefront Biotherapeutics American Depositary Shares (LKFT) in Q2 2026: 672 shares worth $20.1K. The stake represents ﹤0.01% of the portfolio and ranks #1488 among its holdings. This is a return to the name: Mirae Asset Global Investments previously reported a position in LKFT as recently as Q4 2025.
Mirae Asset Global Investments first reported a position in LKFT in Q2 2024 and has held it in 8 quarters since. The position peaked at $23K in Q4 2025. 24 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.
- Mirae Asset Global Investments held 672 shares of Lakefront Biotherapeutics American Depositary Shares worth $20.1K as of Q2 2026.
- Lakefront Biotherapeutics American Depositary Shares was a new Mirae Asset Global Investments position in Q2 2026.
- Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1488 holding.
- Mirae Asset Global Investments first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2024 and has held it in 8 quarters since.
- Mirae Asset Global Investments's Lakefront Biotherapeutics American Depositary Shares position peaked at $23K in Q4 2025.
- 24 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.
Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.